Michel Goedert
Auto-generated profile, based on publicly available information

Michel Goedert

MRC Laboratory of Molecular Biology, Cambridge, UK

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 1998 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MSMaria Grazia Spillantini
Maria Grazia Spillantini
RCR. Anthony Crowther
R. Anthony Crowther
RJRoss Jakes
Ross Jakes
MHMasato Hasegawa
Masato Hasegawa
MGMichel Goedert
Michel Goedert
Lewy bodies and Lewy neurites are the defining neuropathological characteristics of Parkinson’s disease and dementia with Lewy bodies. They are made of abnormal filamentous assemblies of unknown composition. We show here that Lewy bodies and Lewy neurites from Parkinson’s disease and dementia with Lewy bodies are stained strongly by antibodies directed against amino-terminal and carboxyl-terminal sequences of α-synuclein, showing the presence of full-length or close to full-length α-synuclein. The number of α-synuclein-stained structures exceeded that immunoreactive for ubiquitin, which is currently the most sensitive marker of Lewy bodies and Lewy neurites. Staining for α-synuclein thus will replace staining for ubiquitin as the preferred method for detecting Lewy bodies and Lewy neurites. We have isolated Lewy body filaments by a method used for the extraction of paired helical filaments from Alzheimer’s disease brain. By immunoelectron microscopy, extracted filaments were labeled strongly by anti-α-synuclein antibodies. The morphologies of the 5- to 10-nm filaments and their staining characteristics suggest that extended α-synuclein molecules run parallel to the filament axis and that the filaments are polar structures. These findings indicate that α-synuclein forms the major filamentous component of Lewy bodies and Lewy neurites.

5 July 2017 in Nature
Verified
Journal Article
Open access
PDF file
AFAnthony W. P. Fitzpatrick
Anthony W. P. Fitzpatrick
BFBenjamin Falcon
Benjamin Falcon
SHShaoda He
Shaoda He
AMAlexey G. Murzin
Alexey G. Murzin
GMGarib Murshudov
Garib Murshudov
SSSjors H. W. Scheres
Sjors H. W. Scheres
Alzheimer’s disease is the most common neurodegenerative disease, and there are no mechanism-based therapies. The disease is defined by the presence of abundant neurofibrillary lesions and neuritic plaques in the cerebral cortex. Neurofibrillary lesions comprise paired helical and straight tau filaments, whereas tau filaments with different morphologies characterize other neurodegenerative diseases. No high-resolution structures of tau filaments are available. Here we present cryo-electron microscopy (cryo-EM) maps at 3.4–3.5 Å resolution and corresponding atomic models of paired helical and straight filaments from the brain of an individual with Alzheimer’s disease. Filament cores are made of two identical protofilaments comprising residues 306–378 of tau protein, which adopt a combined cross-β/β-helix structure and define the seed for tau aggregation. Paired helical and straight filaments differ in their inter-protofilament packing, showing that they are ultrastructural polymorphs. These findings demonstrate that cryo-EM allows atomic characterization of amyloid filaments from patient-derived material, and pave the way for investigation of a range of neurodegenerative diseases.

3 November 2006 in Science
Verified
Journal Article
Closed access
MGMichel Goedert
Michel Goedert
MSMaria Grazia Spillantini
Maria Grazia Spillantini
One hundred years ago a small group of psychiatrists described the abnormal protein deposits in the brain that define the most common neurodegenerative diseases. Over the past 25 years, it has become clear that the proteins forming the deposits are central to the disease process. Amyloid-β and tau make up the plaques and tangles of Alzheimer's disease, where these normally soluble proteins assemble into amyloid-like filaments. Tau inclusions are also found in a number of related disorders. Genetic studies have shown that dysfunction of amyloid-β or tau is sufficient to cause dementia. The ongoing molecular dissection of the neurodegenerative pathways is expected to lead to a true understanding of disease pathogenesis.

7 June 2009 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
FCFlorence Clavaguera
Florence Clavaguera
TBTristan Bolmont
Tristan Bolmont
RCR. Anthony Crowther
R. Anthony Crowther
DADorothee Abramowski
Dorothee Abramowski
SFStephan Frank
Stephan Frank
MTMarkus Tolnay
Markus Tolnay

1 July 2001 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
MGMichel Goedert
Michel Goedert

27 November 2012 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
MGMichel Goedert
Michel Goedert
MSMaria Grazia Spillantini
Maria Grazia Spillantini
KTKelly Del Tredici
Kelly Del Tredici
HBHeiko Braak
Heiko Braak